InvestSMART

Lumos Diagnostics Holdings Limited (ASX: LDX) - Announcements

- Current share price for LDX : $0.100

ASX company news and announcements for Lumos Diagnostics Holdings Limited (LDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Lumos Diagnostics Holdings Limited (LDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Lumos Diagnostics Holdings Limited (LDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Lumos Diagnostics Holdings Limited (LDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$94 Appendix 4G and Corporate Governance Statement 26 Aug 2026 10:06AM $0.105 $0.100 fallen by 4.76%
$94 FY26 Full Year Results Announcement 26 Aug 2026 9:44AM $0.100 $0.100 fallen by 0%
$94 FY26 Annual Report 26 Aug 2026 9:41AM $0.100 $0.100 fallen by 0%
$94 FY26 Appendix 4E 26 Aug 2026 9:22AM $0.100 $0.100 fallen by 0%
$94 Lumos to Present at 20th Bioshares Biotech Summit 7 Aug 2026 11:02AM $0.120 $0.100 fallen by 16.67%
$94 Lumos Receives FebriDx Order from PHASE Scientific 4 Aug 2026 9:04AM $0.105 $0.100 fallen by 4.76%
$94 Lumos Secures Distribution for FebriDx in Romania 30 Jul 2026 9:38AM $0.100 $0.100 fallen by 0%
$94 Change of Director's Interest Notice - DW 28 Jul 2026 12:42PM $0.103 $0.100 fallen by 2.44%
$94 Section 708A Cleansing Statement 28 Jul 2026 9:40AM $0.100 $0.100 fallen by 0%
$94 Application for quotation of securities - LDX 28 Jul 2026 9:37AM $0.100 $0.100 fallen by 0%
$94 Investor Presentation 27 Jul 2026 12:01PM $0.105 $0.100 fallen by 4.76%
$94 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2026 9:55AM $0.110 $0.100 fallen by 9.09%
$94 FebriDx Commercial Traction Across Priority US Accounts 21 Jul 2026 12:08PM $0.078 $0.100 risen by 28.21%
$94 Q4 FY26 Results Release Date and Webinar Invitation 20 Jul 2026 11:01AM $0.083 $0.100 risen by 20.48%
$94 Investor Information Sessions 20 Jul 2026 10:50AM $0.083 $0.100 risen by 20.48%
$94 Notification of cessation of securities - LDX 14 Jul 2026 1:06PM $0.087 $0.100 risen by 14.94%
$94 Closure of A$5M Loan Facility with Major Shareholders 2 Jul 2026 2:27PM $0.105 $0.100 fallen by 4.76%
$94 Lumos Receives Research & Development Tax Rebate 29 Jun 2026 9:54AM $0.115 $0.100 fallen by 13.04%
$94 Change of Director's Interest Notice - SL 25 Jun 2026 11:48AM $0.105 $0.100 fallen by 4.76%
$94 Application for quotation of securities - LDX 22 Jun 2026 12:12PM $0.115 $0.100 fallen by 13.04%
$94 Change of Director's Interest Notice - CR 19 Jun 2026 9:13AM $0.115 $0.100 fallen by 13.04%
$94 Investor Presentation - FebriDx US Commercial Update 11 Jun 2026 9:58AM $0.105 $0.100 fallen by 4.76%
$94 Change of Director's Interest Notice - DW 5 Jun 2026 2:51PM $0.100 $0.100 fallen by 0%
$94 FebriDx US Commercial Update Webinar Invitation 4 Jun 2026 11:23AM $0.105 $0.100 fallen by 4.76%
$94 Application for quotation of securities - LDX 20 May 2026 1:24PM $0.130 $0.100 fallen by 23.08%

1 - 25 of 548 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.